Researchers find new strategy to help immune system fight pancreatic cancer

by Ezra Xiong, University of Minnesota Medical School

edited by Sadie Harley, reviewed by Andrew Zinin

Sadie Harley

Scientific Editor

Meet our editorial team
Behind our editorial process

Andrew Zinin

Chief Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The GIST Add as preferred source

Researchers from the University of Minnesota Medical School have identified why pancreatic cancer is difficult for the immune system to recognize and attack, paving the way for a new approach to improve immunotherapy. The findings were published in Science Immunology.

The study found that some cancer cells learn how to hide from the immune system by shutting down a process that normally allows immune cells to detect them. Once hidden, these cancer cells are more likely to spread to other parts of the body.

Researchers also discovered that certain immune cells, known as regulatory T cells, prevent other helpful T cells from eliminating these hidden cancer cells.

Restoring the immune system's view

By combining two types of treatment strategies, one that restores the cancer cells' visibility to the immune system and another type of immunotherapy to activate CD4 helper T cells, the researchers were able to improve the immune response and reduce the cancer's ability to spread in preclinical models.

"By following the data, this study has transformed how we think about requirements for an effective immunotherapy for pancreatic cancer," said Ingunn Stromnes, Ph.D., associate professor at the University of Minnesota Medical School and the principal investigator and corresponding author of the study.

CD4 T cells move to center stage

The findings suggest that CD4 helper T cells play a much larger role in fighting pancreatic cancer than previously understood and could become an important strategy in strengthening future immunotherapies.

The next steps are to figure out exactly how CD4 T cells coordinate the immune response and how we can harness them to make immunotherapies more effective. Ultimately, the research team's goal is to translate these findings into new treatments that give patients with pancreatic cancer better options and better outcomes.

Publication details

Zoe C. Schmiechen et al, T _reg cells promote immunotherapy-induced immune evasion by restraining CD4 T cell control of MHC-I–deficient metastatic pancreatic cancer, Science Immunology (2026). DOI: 10.1126/sciimmunol.adz4302

Journal information: Science Immunology

Key medical concepts

Pancreatic CancerImmune SystemImmunotherapyT-Lymphocytes, Regulatory

Clinical categories

OncologyAllergy and immunology Provided by University of Minnesota Medical School Who's behind this story?

Sadie Harley

BSc Life Sciences & Ecology. Microbiology lab background with pharmaceutical news experience in oil, gas, and renewable industries. Full profile →

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Researchers find new strategy to help immune system fight pancreatic cancer (2026, July 21) retrieved 24 July 2026 from https://medicalxpress.com/news/2026-07-strategy-immune-pancreatic-cancer.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.